These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7527107

  • 81. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [Abstract] [Full Text] [Related]

  • 82. Trandolapril does not improve insulin sensitivity in patients with hypertension and type 2 diabetes: a double-blind, placebo-controlled crossover trial.
    Petrie JR, Morris AD, Ueda S, Small M, Donnelly R, Connell JM, Elliott HL.
    J Clin Endocrinol Metab; 2000 May; 85(5):1882-9. PubMed ID: 10843169
    [Abstract] [Full Text] [Related]

  • 83. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F, Hwang IK, Muccilli AC.
    Clin Ther; 1980 May; 3(3):168-75. PubMed ID: 7006811
    [Abstract] [Full Text] [Related]

  • 84.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 85. Verapamil SR and trandolapril combination therapy in hypertension--a clinical trial of factorial design. German Hypertension Study Group.
    Scholze J, Zilles P, Compagnone D.
    Br J Clin Pharmacol; 1998 May; 45(5):491-5. PubMed ID: 9643623
    [Abstract] [Full Text] [Related]

  • 86. Quinapril, hydrochlorothiazide, and combination in patients with moderate to severe hypertension.
    Lenz T, Schulte KL, Wagner B, Lilienthal J, Gotzen R.
    Eur Heart J; 1994 Jul; 15(7):940-6. PubMed ID: 7925516
    [Abstract] [Full Text] [Related]

  • 87. Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group.
    Weir MR, Gray JM, Paster R, Saunders E.
    Hypertension; 1995 Jul; 26(1):124-30. PubMed ID: 7607715
    [Abstract] [Full Text] [Related]

  • 88. Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients.
    Vaur L, Bobrie G, Dutrey-Dupagne C, Dubroca I, Vaisse B, d'Yvoire MB, Elkik F, Chatellier G, Menard J.
    Am J Hypertens; 1998 Feb; 11(2):165-73. PubMed ID: 9524044
    [Abstract] [Full Text] [Related]

  • 89. Antihypertensive effects of indoramin and prazosin in combination with hydrochlorothiazide.
    Solomon R.
    J Cardiovasc Pharmacol; 1986 Feb; 8 Suppl 2():S56-62. PubMed ID: 2423799
    [Abstract] [Full Text] [Related]

  • 90. Once-daily trandolapril compared with the twice-daily formulation in the treatment of mild to moderate essential hypertension: assessment by conventional and ambulatory blood pressures.
    Poirier L, Bourgeois J, Lacourcière Y.
    J Clin Pharmacol; 1993 Sep; 33(9):832-6. PubMed ID: 8227480
    [Abstract] [Full Text] [Related]

  • 91. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
    Hill JF, Bulpitt CJ, Fletcher AE.
    J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
    [Abstract] [Full Text] [Related]

  • 92. Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension.
    Wiseman LR, McTavish D.
    Drugs; 1994 Jul; 48(1):71-90. PubMed ID: 7525196
    [Abstract] [Full Text] [Related]

  • 93. Perindopril/hydrochlorothiazide dose combinations for the treatment of hypertension: a multicenter study.
    Chrysant SG.
    J Clin Pharmacol; 1997 Jan; 37(1):47-52. PubMed ID: 9048272
    [Abstract] [Full Text] [Related]

  • 94. Double-blind study of dilevalol and captopril, both in combination with hydrochlorothiazide, in patients with moderate to severe hypertension.
    McGrath BP, Matthews PG, Louis W, Howes L, Whitworth JA, Kincaid-Smith PS, Fraser I, Scheinkestel C, MacDonald G, Rallings M.
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):831-8. PubMed ID: 1703608
    [Abstract] [Full Text] [Related]

  • 95. Antihypertensive efficacy of a once a day verapamil SR/trandolapril combination.
    Oren S, Viskoper JR, Zilles P.
    Int J Cardiol; 1996 Jul 05; 55(1):97-102. PubMed ID: 8839816
    [Abstract] [Full Text] [Related]

  • 96. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy.
    Burris JF, Weir MR, Oparil S, Weber M, Cady WJ, Stewart WH.
    JAMA; 1990 Mar 16; 263(11):1507-12. PubMed ID: 2407872
    [Abstract] [Full Text] [Related]

  • 97. Comparison of moexipril, a new ACE inhibitor, to verapamil-SR as add-on therapy to low dose hydrochlorothiazide in hypertensive patients.
    Chrysant SG, Fox AA, Stimpel M.
    Am J Hypertens; 1995 Apr 16; 8(4 Pt 1):418-21. PubMed ID: 7619356
    [Abstract] [Full Text] [Related]

  • 98. Indoramin as second step therapy in the management of benign essential hypertension.
    Montenero AS, Mazzari M, Schiavoni G, Manzoli U, Gherardi S.
    Pharmatherapeutica; 1983 Apr 16; 3(6):417-21. PubMed ID: 6353433
    [Abstract] [Full Text] [Related]

  • 99. The effect of perindopril and hydrochlorothiazide alone and in combination on blood pressure and on the renin-angiotensin system in hypertensive subjects.
    Brown CL, Backhouse CI, Grippat JC, Santoni JP.
    Eur J Clin Pharmacol; 1990 Apr 16; 39(4):327-32. PubMed ID: 2076713
    [Abstract] [Full Text] [Related]

  • 100. Fixed combination verapamil SR/trandolapril.
    Dooley M, Goa KL.
    Drugs; 1998 Nov 16; 56(5):837-44; discussion 845-6. PubMed ID: 9829157
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.